Seres Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Seres Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2014 to Q3 2024.
  • Seres Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $5.18M, a 40.2% decline year-over-year.
  • Seres Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $22.3M, a 38.6% decline year-over-year.
  • Seres Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $34.1M, a 33.8% increase from 2022.
  • Seres Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $25.5M, a 26% increase from 2021.
  • Seres Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $20.2M, a 129% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $22.3M $5.18M -$3.49M -40.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $25.8M $5.53M -$7.96M -59% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $33.7M $6.49M -$361K -5.27% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $34.1M $5.09M -$2.21M -30.2% Oct 1, 2023 Dec 31, 2023 8-K 2024-08-15
Q3 2023 $36.3M $8.67M +$2.31M +36.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $34M $13.5M +$6.74M +99.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $27.3M $6.85M +$1.77M +34.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $25.5M $7.29M +$1.62M +28.5% Oct 1, 2022 Dec 31, 2022 8-K 2024-08-15
Q3 2022 $23.9M $6.36M +$518K +8.86% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $23.3M $6.75M +$1.67M +32.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $21.7M $5.08M +$1.46M +40.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $20.2M $5.67M +$2.97M +110% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 $17.3M $5.85M +$3.6M +160% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $13.7M $5.08M +$3.16M +165% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $10.5M $3.62M +$1.67M +85% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $8.82M $2.7M +$557K +26% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-07
Q3 2020 $8.27M $2.25M +$212K +10.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $8.06M $1.91M -$183K -8.73% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $8.24M $1.96M -$106K -5.13% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $8.34M $2.15M -$1.61M -42.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $9.95M $2.04M -$2.28M -52.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $12.2M $2.1M -$2.24M -51.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-28
Q1 2019 $14.5M $2.07M -$2.17M -51.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $16.6M $3.75M -$457K -10.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-02
Q3 2018 $17.1M $4.32M -$52K -1.19% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $17.2M $4.33M -$169K -3.75% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $17.3M $4.24M -$43K -1.01% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $17.4M $4.21M +$219K +5.49% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $17.1M $4.37M +$125K +2.95% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $17M $4.5M -$214K -4.54% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $17.2M $4.28M +$375K +9.61% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $16.9M $3.99M +$1.21M +43.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-06
Q3 2016 $15.7M $4.24M +$1.74M +69.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $13.9M $4.72M +$1.64M +53.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $12.3M $3.9M +$2.58M +194% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $9.69M $2.79M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 $2.51M +$1.9M +316% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $3.07M +$3.02M +5810% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $1.33M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q3 2014 $603K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $52K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.